Overview

A Phase 1b Study to Evaluate the Safety of XEN-101

Status:
TERMINATED
Trial end date:
2024-09-09
Target enrollment:
Participant gender:
Summary
This Phase 1b study will evaluate the effects of XEN-101 in subjects with obesity
Phase:
PHASE1
Details
Lead Sponsor:
Xeno Biosciences